Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.
By John B. Buse, J. Bigger, R. Byington, L. Cooper, W. Cushman, W. Friedewald, S. Genuth, H. Gerstein, H. Ginsberg, D. Goff and 5 more. American Journal of Cardiology, 2007
638 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Surgery
View Paper: https://www.semanticscholar.org/paper/5d45efae23a9a676266575f95c0196d49a14ac1a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Surgery
Citations in the corpus
- Achieving desired results and improved outcomes: Integrating planning and assessment throughout learning activities (2009, background): “0, currently regarded as standard glycemic control.(69) We would be looking, therefore, for information about this health status measure, hemoglobin A1c.”
- The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study (2010, positive): “The ACCORD study is a double 2×2 factorial trial designed to test the effect of intensive glucose control compared with standard glucose control, intensive blood pressure control compared with standard blood pressure control, and a lipid treatment strategy that uses fenofibrate plus a statin compare”
- Case Report: Electronic Screening Improves Efficiency in Clinical Trial Recruitment (2009, methodology): “The ACCORD is a challenging case for E-screening because it has 6 major inclusion and 19 major exclusion criteria as well as 5 eligibility criteria associated with substudies.(8) We believed that an E-screening method that worked well in a complex trial like ACCORD would likely be applicable to many”